Lisa Schnell

Title: Lisa Schnell - Innovator in Nerve Repair Therapeutics

Introduction

Lisa Schnell is a prominent inventor based in Zurich, Switzerland. She has made significant contributions to the field of pharmaceuticals, particularly in the area of nerve repair. With a total of 2 patents, her work focuses on innovative therapeutic solutions.

Latest Patents

One of her latest patents is titled "Antibody (11C7) anti Nogo-A and its pharmaceutical use." This invention relates to molecules, such as monoclonal antibodies or Fab fragments, which are capable of binding to the human NogoA polypeptide. The binding molecules have a dissociation constant of less than 1000 nM. The patent also includes polynucleotides encoding such binding molecules, expression vectors comprising these polynucleotides, and their use in treating nerve repair. Additionally, it covers pharmaceutical compositions that include these binding molecules and methods for treating diseases associated with nerve repair.

Career Highlights

Lisa has worked with notable organizations such as Novartis AG and the University of Zurich. Her experience in these institutions has allowed her to develop her expertise in pharmaceutical innovations.

Collaborations

Some of her coworkers include Carmen Barske and Anis Khusro Mir. Their collaborative efforts have contributed to advancements in her research and inventions.

Conclusion

Lisa Schnell is a key figure in the development of therapeutic solutions for nerve repair, with her innovative patents paving the way for future advancements in this critical area of medicine.